Similarly, preclinical studies using KRAS G12C-mutant mouse models with STK11/LKB1 deletions have identified adenocarcinoma-to-squamous cell carcinoma transformation (AST) as a pathological feature linked to primary drug resistance (103). This evidence concerns the gene STK11 and adenocarcinoma.